Lastly, an effect of IL-33 on maintenance of CD34+ cells from CML subjects was demonstrated by using xenotransplant experiments in immunodeficient NOD Shi-SCID IL2Rγcnul (NOG) mice [77]. This evidence concerns the gene IL33 and chronic myelogenous leukemia, BCR-ABL1 positive.